2-[2-hydroxy-7,7-dimethyl-1-spiro[1H-indene-1,4'-(hexahydropyridine)]-1-ylsulfonylmethyl-(1S,2S,4R)-bicyclo[2.2.1]hept-2-yl]acetic acid

ID: ALA341339

Chembl Id: CHEMBL341339

Cas Number: 138382-23-7

PubChem CID: 9981665

Max Phase: Preclinical

Molecular Formula: C25H33NO5S

Molecular Weight: 459.61

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2

Standard InChI:  InChI=1S/C25H33NO5S/c1-22(2)19-8-10-24(22,25(29,15-19)16-21(27)28)17-32(30,31)26-13-11-23(12-14-26)9-7-18-5-3-4-6-20(18)23/h3-7,9,19,29H,8,10-17H2,1-2H3,(H,27,28)/t19-,24+,25+/m1/s1

Standard InChI Key:  XKVDTEPESVJNPJ-NGXZDTIWSA-N

Alternative Forms

  1. Parent:

    ALA341339

    CID 9981665

Associated Targets(Human)

OXTR Tclin Oxytocin receptor (1962 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Oxtr Oxytocin receptor (839 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Avpr1b Vasopressin V1 receptor (358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Avpr2 Vasopressin V2 receptor (776 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Avpr1a Vasopressin V1a receptor (612 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 459.61Molecular Weight (Monoisotopic): 459.2079AlogP: 3.41#Rotatable Bonds: 5
Polar Surface Area: 94.91Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 4.16CX Basic pKa: CX LogP: 2.27CX LogD: -0.79
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.70Np Likeness Score: 0.68

References

1. Evans BE, Lundell GF, Gilbert KF, Bock MG, Rittle KE, Carroll LA, Williams PD, Pawluczyk JM, Leighton JL, Young MB..  (1993)  Nanomolar-affinity, non-peptide oxytocin receptor antagonists.,  36  (25): [PMID:8258821] [10.1021/jm00077a002]
2. Borthwick AD..  (2010)  Oral oxytocin antagonists.,  53  (18): [PMID:20550119] [10.1021/jm901812z]

Source